Skip to main content
menu
URMC / Research / Health Research / Clinical Trials / Clinical Trials Details

widget-2a8a22ab-02e

 

widget-6da1f1b7-831

Return to Search


PMLT12010 / ALTE05N1 / Kazi

NA

Lead Researcher: Rafi Kazi

This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.

Eligibility:

Inclusion Criteria:

* The patient must reside in the U.S. on the date of enrollment to ALTE05N1
* All patients and/or their parents or legal guardians must sign a written informed consent
* All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

Want to contact the study?

This field is required
This field is required
You must agree to be contacted to continue.